Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-18 Sale | 2024-09-19 4:30 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $14 | $140,000 | 600,281 (Direct) | View |
| 2024-08-19 Sale | 2024-08-21 6:51 pm | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $14 | $140,000 | 610,281 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-18 Exercise | 2024-09-19 4:30 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $0 | 600,281 (Direct) | View |
| 2024-09-18 Exercise | 2024-09-19 4:30 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $1.5 | 600,281 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-21 6:51 pm | N/A 2032-05-23 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $0 | 610,281 (Direct) | View |
| 2024-08-19 Exercise | 2024-08-21 6:51 pm | N/A N/A | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 10,000 | $1.5 | 610,281 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:47 pm | N/A 2034-01-01 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 5:00 pm | N/A 2033-01-02 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-11-08 Option Award | 2022-11-10 6:00 pm | N/A 2032-05-24 | ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer | 614,588 | $0 | 614,588 (Direct) | View |